• Clinical Pathway
  • Science
  • Patient Experience
  • Leadership
  • Newsroom
  • Investors

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Updates

  • PhotoPharmics Announces Publication of Phase 2 Clinical Trial Results in Neurotherapeutics and Its Role in the Company’s Phase 3/Pivotal Clinical Trial
    January 20, 2026
  • PhotoPharmics Announces Board Expansion to Support the Next Phases of Growth: Clinical Execution, Commercialization, and Strategic Partnerships
    December 4, 2025
  • PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote, Home-Based Phase 3 “Light for PD” Clinical Trial
    November 5, 2025
  • PhotoPharmics to Feature Photo Neurostimulation at the 2025 Movement Disorders Society International Congress
    October 3, 2025
  • PhotoPharmics Forms Commercial Advisory Board to Guide Market Launch of Breakthrough Parkinson’s Therapy
    August 28, 2025

Articles & Insights

  • Understanding Parkinson’s Fatigue
    Understanding Parkinson’s Fatigue
    December 23, 2025
  • The Role of Nutrition in Parkinson’s Disease
    The Role of Nutrition in Parkinson’s Disease
    November 30, 2025
  • Young-Onset Parkinson’s: Navigating Your Journey After an Early Diagnosis
    Young-Onset Parkinson’s: Navigating Your Journey After an Early Diagnosis
    October 23, 2025

Quick Links

  • Contact Us
  • Investors
  • Newsroom
  • Follow
  • Follow
  • Follow
  • Follow

PHOTOPHARMICS, INC.

3450 North Triumph Boulevard
Lehi, UT 84043 USA

Phone
+1 (801) 770-6960

© 2025 PhotoPharmics. All Rights Reserved.   |   Privacy Policy  |  Terms of Use